Royal Bank of Canada Reduces Holdings in Mettler-Toledo International, Inc. $MTD

Key Points

• Royal Bank of Canada has decreased its stake in Mettler-Toledo International by 14.8%, selling 6,787 shares and now owning approximately 0.19% of the company, valued at about $46 million.
• Research analysts are mixed on Mettler-Toledo, with ratings ranging from buy to hold, and a consensus price target of $1,311.11.
• Recent quarterly earnings exceeded expectations, with Mettler-Toledo reporting a net margin of 21.46% and earnings of $10.09 per share.

Royal Bank of Canada lessened its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 14.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 38,969 shares of the medical instruments supplier's stock after selling 6,787 shares during the quarter. Royal Bank of Canada owned 0.19% of Mettler-Toledo International worth $46,020,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. GAMMA Investing LLC boosted its position in shares of Mettler-Toledo International by 131,246.3% during the 1st quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock worth $456,018,000 after purchasing an additional 385,864 shares during the period. Nuveen LLC acquired a new position in Mettler-Toledo International during the first quarter worth $71,897,000. AustralianSuper Pty Ltd boosted its position in shares of Mettler-Toledo International by 60.4% during the first quarter. AustralianSuper Pty Ltd now owns 114,986 shares of the medical instruments supplier's stock worth $135,788,000 after buying an additional 43,313 shares during the period. T. Rowe Price Investment Management Inc. grew its stake in shares of Mettler-Toledo International by 11.9% in the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier's stock valued at $479,673,000 after buying an additional 43,082 shares in the last quarter. Finally, Millennium Management LLC raised its holdings in shares of Mettler-Toledo International by 2,411.4% in the 4th quarter. Millennium Management LLC now owns 43,346 shares of the medical instruments supplier's stock valued at $53,042,000 after buying an additional 41,620 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of the stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the transaction, the insider directly owned 94 shares of the company's stock, valued at approximately $123,012.16. This trade represents a 63.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Shawn Vadala sold 300 shares of the firm's stock in a transaction that occurred on Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares of the company's stock, valued at $6,389,588.55. The trade was a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,827 shares of company stock worth $2,371,208. Company insiders own 1.94% of the company's stock.

Mettler-Toledo International Stock Up 2.2%

NYSE:MTD traded up $27.41 during mid-day trading on Thursday, reaching $1,280.28. 148,512 shares of the stock were exchanged, compared to its average volume of 116,370. The stock has a market capitalization of $26.37 billion, a P/E ratio of 32.42, a P/E/G ratio of 3.76 and a beta of 1.37. The company has a 50 day simple moving average of $1,257.96 and a 200-day simple moving average of $1,186.40. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. During the same quarter in the prior year, the firm earned $9.65 EPS. Mettler-Toledo International's revenue for the quarter was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, research analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts recently commented on MTD shares. Citigroup raised their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a report on Thursday, August 21st. Barclays began coverage on shares of Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price objective for the company. Evercore ISI cut their target price on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research note on Monday, August 4th. Bank of America increased their price objective on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. Finally, UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their target price for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $1,311.11.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.